Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Download White Paper
IT in
Healthcare,
Patient
Monitoring &
Telemedicine

Download White Paper

 
Matching geography
Reports matching your search in:
 
 
Download SlideShare
20
Hot
Stats on
Healthcare
IT

Download SlideShare

 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Genomics: market research reports

1594
RSS Feeds

Genomics market research reports and industry analysis

< prev 4  5  6  7  8  9  10  11  12  13  next >
The 2010-2015 World Outlook for DNA Chips
7/7/2009 | published by: Icon Group International, Inc.
... question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ...  |  read more...
$795.00
The 2010-2015 World Outlook for Genetic Testing Services
7/7/2009 | published by: Icon Group International, Inc.
... in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ...  |  read more...
$795.00
Personalized Medicine: Technologies and the Global Market
7/1/2009 | published by: BCC Research
... for the worldwide market for personalized medicine Estimates the growth of all submarkets for personalized medicine in terms of technology, products, services, geography and applications areas Analyzes the current personalized medicine business model and looks ...  |  read more...
$5,450.00
MicroRNA Research Trends 2009 Market Report
7/1/2009 | published by: Select Biosciences Limited
... research space with emphasis upon the analysis of microRNAs and microRNA associations with specific physiological and pathological/disease processes. An important feature of this market report are the extensive primary market analyses data including primary market ...  |  read more...
$2,640.00
Competitor Analysis: Bcr-Abl and Src Kinase Inhibitors
7/1/2009 | published by: La Merie Publishing
... Chronic myeloid leukemia (CML) is characterized by the presence of the Philadelphia (Ph) chromosome, which results from a reciprocal translocation between the long arms of the chromosomes 9 and 22 t(9;22)(q34;q11). This translocation creates two ...  |  read more...
$840.00
Exploring the Epigenetics Market: Opportunities for Product Placement and Innovation
7/1/2009 | published by: BioInformatics, LLC
... methylation, histone modifications and chromatin structures all play a central role in the regulation and expression of mammalian genomes and are the central focus of much research today. Breakthroughs in epigenetics have also increased our ...  |  read more...
$3,200.00
Small Molecule Kinase Inhibitors
7/1/2009 | published by: Global Industry Analysts
... period 2006 through 2015. The report profiles 83 companies including many key and niche players worldwide such as Amgen, Inc., Asahi Kasei Pharma Corporation, AstraZeneca plc., Bayer Schering Pharma AG, Bristol-Myers Squibb Company,.Celgene Corporation, Exelixis, ...  |  read more...
$3,950.00
Nucleic Acid Amplification Life Science Dashboard™ Series 2
7/1/2009 | published by: Percepta Associates, Inc.
... expression. The Nucleic Acid Amplification Dashboard was developed from responses to a 21-question survey by 485 scientists predominantly located in North America and Europe. This Dashboard reveals key market indicators for the nucleic acid amplification ...  |  read more...
$3,850.00
Advances in Biomarkers (Technical Insights)
6/30/2009 | published by: Frost & Sullivan
This research service outlines the key global developments in the field of biomarkers.  |  read more...
$6,500.00
Key Trends Fueling the Boom in Genetic Testing
6/15/2009 | published by: Decision Resources
... discover genetic markers that predict disease, diagnose disease, and guide prescribing. Applications of genetic tests are evolving as the technologies to refine them are improving-in addition to the typical diagnostic/biopharma client, interest is fl ourishing ...  |  read more...
$4,600.00
Pharmacogenomics for Clinical Use and in Drug Development
6/1/2009 | published by: TriMark Publications
... based on their particular responses to a drug. The knowledge of the likely effectiveness of a drug in a patient makes the drug more reliable, and fewer drugs would have to be taken off the ...  |  read more...
$3,400.00
Pharmacogenomics: Delivering on the Promise
6/1/2009 | published by: CHI Insight Pharma Reports
... considers: Drivers of PGx Applications of PGx in drug development Industry experiences with PGx and lessons learned Type of evidence needed to establish clinical utility Challenges to moving PGx forward Survey results and expert views ...  |  read more...
$2,995.00
Competitor Analysis: Aurora Kinase Inhibitors
6/1/2009 | published by: La Merie Publishing
... tumor growth, is highly regulated to ensure accurate and equal segregation of genetic materials from parent cells to daughter cells. Main effectors of this process are mitotic spindles and centrosomes.157 Disruption of the process results ...  |  read more...
$250.00
Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges
6/1/2009 | published by: Business Insights
... The potential for molecular diagnostics to be used as companion products for personalized treatments that are based on patient characteristics will contribute to a growing trend for new partnerships between drug companies and diagnostic firms. ...  |  read more...
$3,835.00
Nucleic Acid Purification Life Science Dashboard™ Series 2
6/1/2009 | published by: Percepta Associates, Inc.
... Dashboard was developed from responses to a 20-question survey of 488 scientists predominantly located in North America and Europe. This Dashboard reveals key market indicators for the nucleic acid purification market as a whole as ...  |  read more...
$3,850.00
Next-Generation Sequencing: Solving the Genome
6/1/2009 | published by: CHI Insight Pharma Reports
... they compare Market dynamics and competitive landscape for new entrants Next-generation systems in development Bioinformatics issues Applications of NGS User survey results and views of interviewees The first generation of DNA sequencing can be said ...  |  read more...
$2,995.00
Strategic Analysis of the European Markets for Theranostics
5/26/2009 | published by: Frost & Sullivan
... market, its dynamics and the regulatory scenario. It also includes competitive analysis and strategic recommendations for current industry challenges. In this research, Frost & Sullivan's expert analysts thoroughly examine the key applications of theranostics in ...  |  read more...
$6,500.00
European Lab-on-chip and Microfluidics Markets
5/20/2009 | published by: Frost & Sullivan
This research service gives a detailed analysis of the lab-on-chip and microfluidics market in Europe from 2005-2015.  |  read more...
$6,500.00
Nucleic Acid Testing: A Vehicle for Advancing Personalized Medicine
4/17/2009 | published by: Decision Resources
... used to discover new biomarkers and develop in vitro diagnostics. Companies large and small are recognizing the value of NAT, and both R&D and dealmaking activity is robust. Find out who the players are and ...  |  read more...
$4,600.00
Stakeholder Opinions: Hematopoietic Stem Cell Transplantation - In need of further research and development
4/10/2009 | published by: Datamonitor
... the treatment of certain hematologic malignancies. However, further research efforts are required to expand its use and improve patient outcomes. Scope Usage data for HSCT and overview of the procedure in terms of stem cell ...  |  read more...
$3,800.00
Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players)
4/1/2009 | published by: Kalorama Information
... personalized medicine promises to bring about a new standard of healthcare, with the possiblity to increase profits, speed clinical trials, achieve better clinical results and satisfy patients. But how can companies earn revenue in this ...  |  read more...
$995.00
Choices In Cord Blood Banking: Factors Influencing Parental Decision-Making
4/1/2009 | published by: BioInformant Worldwide, L.L.C.
... genetic and metabolic disorders, immunodeficiencies and various forms of cancer. However, many expectant parents still do not fully understand the significance of cord blood storage. A study published in the Journal of Reproductive Medicine shows ...  |  read more...
$3,295.00
Assessment of Innovations in Biochips (Technical Insights)
3/31/2009 | published by: Frost & Sullivan
This research service discusses the assessment of innovations in biochips.  |  read more...
$6,500.00
Strategic Analysis of U.S. MicroRNA Services Markets
3/31/2009 | published by: Frost & Sullivan
... growing competition and other limitations. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: microRNA expression profiling and phenotypic screening. Market Overview Researchers’ Need for Swift and Precise Results to Publish ...  |  read more...
$6,000.00
Dealmaking and Business Strategies in the Age of Personalized Medicine
3/26/2009 | published by: Decision Resources
... still worried. They do not understand how this area will play out and are risk-averse to working in the brave new world of RxDx regulation. In addition, the ability to mine large databases for clinical, ...  |  read more...
$4,600.00
< prev 4  5  6  7  8  9  10  11  12  13  next >